Here are relevant reports on : clinical-trial-imaging-service-market
-
North America Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030
The North America Proteomics market, valued at USD13.06 billion in 2024, stood at USD14.11 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of USD25.62 billion by the end of the period. The growing use of proteomics in precision oncology, cardiology, and other complex diseases, together with strong momentum in clinical trials, is driving demand for high-throughput, reliable platforms in hospitals and research centers.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA), Application (Therapeutic, Research, Diagnostics), End User (Pharma, Biotech), Region, Competition - Global Forecast to 2031
The global oligonucleotide CDMO market is projected to reach USD 11.14 billion by 2031, growing at a CAGR of 23.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Stem Cell Banking Market by Source (PSC, BMSC, ADSC, hESC, DPSC, NSC), Service Type (Sample Processing, Analysis, Collection, Storage), Application (Personalized Storage, Clinical (Autoimmune, Hematopoietic Disorders), Research) - Global Forecasts to 2023
The global stem cell banking market is projected to reach USD 9.30 Billion by 2023, at a CAGR of 8.2%. Major players in the global stem cell banking market include Cord Blood Registry (CBR) Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), and CryoHoldco (Mexico).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Veterinary Reference Laboratory Market by Service (Microbiology, Immunodiagnostics, Molecular Diagnostics, PCR, ELISA, Hematology, Urinalysis), Animal (Companion, Livestock), Application (Clinical Pathology, Toxicology), Region - Global Forecast to 2030
The global veterinary reference laboratory market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$6.45 billion by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
The latin american flow cytometry market size is projected to reach USD 379 million by 2027, at a CAGR of 7.1% during the forecast period. Key players in this market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Cytek Biosciences, Inc. (US), and Luminex Corporation (US).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Asia Pacific Proteomics Market by Instrumentation [Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray], Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery) - Forecast to 2030
The Asia Pacific Proteomics Market, valued at USD 7.82 billion in 2024, stood at USD 8.57 billion in 2025 and is projected to advance at a resilient CAGR of 14.1% from 2025 to 2030, culminating in a forecasted valuation of USD 16.61 billion by the end of the period. Proteomics focuses on measuring dynamic protein expression, modifications, and interactions at scale, enabling deeper insights into disease biology and treatment response for oncology, neurology, and other complex indications.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Computer Assisted Coding Market by Software (Natural Language Processing, Structured Input, Integrated Systems), Service (Support, Education & Training), Application (Automated Encoding, Clinical Coding Audit, Management Reporting) - Global Forecast to 2022
The global computer-assisted coding market is valued at USD 2.76 Billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 Billion by 2022. In 2016, 3M Company (U.S.) and Optum, Inc. (U.S.) dominated the global computer-assisted coding market. Some of the prominent players in the market are Nuance Communications, Inc. (U.S.), Cerner Corporation (U.S.) and Artificial Medical Intelligence, Inc. (U.S.). Some of the other leading players in this market are Dolbey Systems, Inc. (U.S.), Precyse Solutions, LLC (U.S.), Craneware plc (U.K.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Streamline Health Solutions, Inc. (U.S.), MMODAL IP LLC (M*Modal) (U.S.), TruCode (U.S.), Quest Diagnostics Inc. (U.S.), and Epic Systems Corporation(U.S.).
- Published: July 2017
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030
The global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
The global pharmacogenomics market, valued at US$3.3 billion in 2022, stood at US$3.5 billion in 2023 and is projected to advance at a resilient CAGR of 10.6% from 2023 to 2028, culminating in a forecasted valuation of US$5.8 billion by the end of the period. The increasing focus on the translational approach to optimize drug development processes, increasing collaborations and partnerships between key players and research institutes, and rising incidence of cancer are the major driving factors of the pharmacogenomics market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
